Data Demonstrating the Safety and Efficacy of Chimerix's Antiviral CMX001 ... PharmaLive (press release) (subscription) No evidence of CMX001-associated kidney toxicity was seen in stem cell transplant recipients who were enrolled in a 230-patient Phase 2 study to evaluate CMX001 for prevention of cytomegalovirus (CMV) infection. Subjects on CMX001 had stable to ... |
